Cargando…

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

We compared the performance of SARS-CoV-2 neutralising antibody testing between 12 European laboratories involved in convalescent plasma trials. Raw titres differed almost 100-fold differences between laboratories when blind-testing 15 plasma samples. Calibration of titres in relation to the referen...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Dung, Simmonds, Peter, Steenhuis, Maurice, Wouters, Elise, Desmecht, Daniel, Garigliany, Mutien, Romano, Marta, Barbezange, Cyril, Maes, Piet, Van Holm, Bram, Mendoza, Joaquín, Oyonarte, Salvador, Fomsgaard, Anders, Lassaunière, Ria, Zusinaite, Eva, Resman Rus, Katarina, Avšič-Županc, Tatjana, Reimerink, Johan HJ, Brouwer, Fiona, Hoogerwerf, Marieke, Reusken, Chantal BEM, Grodeland, Gunnveig, Le Cam, Sophie, Gallian, Pierre, Amroun, Abdennour, Brisbarre, Nadège, Martinaud, Christophe, Leparc Goffart, Isabelle, Schrezenmeier, Hubert, Feys, Hendrik B, van der Schoot, C Ellen, Harvala, Heli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268650/
https://www.ncbi.nlm.nih.gov/pubmed/34240697
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.27.2100568
_version_ 1783720404356956160
author Nguyen, Dung
Simmonds, Peter
Steenhuis, Maurice
Wouters, Elise
Desmecht, Daniel
Garigliany, Mutien
Romano, Marta
Barbezange, Cyril
Maes, Piet
Van Holm, Bram
Mendoza, Joaquín
Oyonarte, Salvador
Fomsgaard, Anders
Lassaunière, Ria
Zusinaite, Eva
Resman Rus, Katarina
Avšič-Županc, Tatjana
Reimerink, Johan HJ
Brouwer, Fiona
Hoogerwerf, Marieke
Reusken, Chantal BEM
Grodeland, Gunnveig
Le Cam, Sophie
Gallian, Pierre
Amroun, Abdennour
Brisbarre, Nadège
Martinaud, Christophe
Leparc Goffart, Isabelle
Schrezenmeier, Hubert
Feys, Hendrik B
van der Schoot, C Ellen
Harvala, Heli
author_facet Nguyen, Dung
Simmonds, Peter
Steenhuis, Maurice
Wouters, Elise
Desmecht, Daniel
Garigliany, Mutien
Romano, Marta
Barbezange, Cyril
Maes, Piet
Van Holm, Bram
Mendoza, Joaquín
Oyonarte, Salvador
Fomsgaard, Anders
Lassaunière, Ria
Zusinaite, Eva
Resman Rus, Katarina
Avšič-Županc, Tatjana
Reimerink, Johan HJ
Brouwer, Fiona
Hoogerwerf, Marieke
Reusken, Chantal BEM
Grodeland, Gunnveig
Le Cam, Sophie
Gallian, Pierre
Amroun, Abdennour
Brisbarre, Nadège
Martinaud, Christophe
Leparc Goffart, Isabelle
Schrezenmeier, Hubert
Feys, Hendrik B
van der Schoot, C Ellen
Harvala, Heli
author_sort Nguyen, Dung
collection PubMed
description We compared the performance of SARS-CoV-2 neutralising antibody testing between 12 European laboratories involved in convalescent plasma trials. Raw titres differed almost 100-fold differences between laboratories when blind-testing 15 plasma samples. Calibration of titres in relation to the reference reagent and standard curve obtained by testing a dilution series reduced the inter-laboratory variability ca 10-fold. The harmonisation of neutralising antibody quantification is a vital step towards determining the protective and therapeutic levels of neutralising antibodies.
format Online
Article
Text
id pubmed-8268650
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-82686502021-07-16 SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data Nguyen, Dung Simmonds, Peter Steenhuis, Maurice Wouters, Elise Desmecht, Daniel Garigliany, Mutien Romano, Marta Barbezange, Cyril Maes, Piet Van Holm, Bram Mendoza, Joaquín Oyonarte, Salvador Fomsgaard, Anders Lassaunière, Ria Zusinaite, Eva Resman Rus, Katarina Avšič-Županc, Tatjana Reimerink, Johan HJ Brouwer, Fiona Hoogerwerf, Marieke Reusken, Chantal BEM Grodeland, Gunnveig Le Cam, Sophie Gallian, Pierre Amroun, Abdennour Brisbarre, Nadège Martinaud, Christophe Leparc Goffart, Isabelle Schrezenmeier, Hubert Feys, Hendrik B van der Schoot, C Ellen Harvala, Heli Euro Surveill Rapid Communication We compared the performance of SARS-CoV-2 neutralising antibody testing between 12 European laboratories involved in convalescent plasma trials. Raw titres differed almost 100-fold differences between laboratories when blind-testing 15 plasma samples. Calibration of titres in relation to the reference reagent and standard curve obtained by testing a dilution series reduced the inter-laboratory variability ca 10-fold. The harmonisation of neutralising antibody quantification is a vital step towards determining the protective and therapeutic levels of neutralising antibodies. European Centre for Disease Prevention and Control (ECDC) 2021-07-08 /pmc/articles/PMC8268650/ /pubmed/34240697 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.27.2100568 Text en This article is copyright of the authors or their affiliated institutions, 2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Nguyen, Dung
Simmonds, Peter
Steenhuis, Maurice
Wouters, Elise
Desmecht, Daniel
Garigliany, Mutien
Romano, Marta
Barbezange, Cyril
Maes, Piet
Van Holm, Bram
Mendoza, Joaquín
Oyonarte, Salvador
Fomsgaard, Anders
Lassaunière, Ria
Zusinaite, Eva
Resman Rus, Katarina
Avšič-Županc, Tatjana
Reimerink, Johan HJ
Brouwer, Fiona
Hoogerwerf, Marieke
Reusken, Chantal BEM
Grodeland, Gunnveig
Le Cam, Sophie
Gallian, Pierre
Amroun, Abdennour
Brisbarre, Nadège
Martinaud, Christophe
Leparc Goffart, Isabelle
Schrezenmeier, Hubert
Feys, Hendrik B
van der Schoot, C Ellen
Harvala, Heli
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
title SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
title_full SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
title_fullStr SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
title_full_unstemmed SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
title_short SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
title_sort sars-cov-2 neutralising antibody testing in europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268650/
https://www.ncbi.nlm.nih.gov/pubmed/34240697
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.27.2100568
work_keys_str_mv AT nguyendung sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT simmondspeter sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT steenhuismaurice sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT wouterselise sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT desmechtdaniel sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT gariglianymutien sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT romanomarta sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT barbezangecyril sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT maespiet sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT vanholmbram sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT mendozajoaquin sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT oyonartesalvador sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT fomsgaardanders sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT lassauniereria sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT zusinaiteeva sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT resmanruskatarina sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT avsiczupanctatjana sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT reimerinkjohanhj sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT brouwerfiona sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT hoogerwerfmarieke sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT reuskenchantalbem sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT grodelandgunnveig sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT lecamsophie sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT gallianpierre sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT amrounabdennour sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT brisbarrenadege sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT martinaudchristophe sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT leparcgoffartisabelle sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT schrezenmeierhubert sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT feyshendrikb sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT vanderschootcellen sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata
AT harvalaheli sarscov2neutralisingantibodytestingineuropetowardsharmonisationofneutralisingantibodytitresforbetteruseofconvalescentplasmaandcomparabilityoftrialdata